Perrigo — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 11 events
Perrigo commits to upholding human rights and environmental standards in its supply chain through rigorous monitoring programs and collaboration with suppliers who share its values. This is positioned as a Scope 3 / supplier-engagement lever, though no quantitative supplier engagement targets are disclosed in the 10-K.
sustainability_report p.15
Sold Rare Diseases Business to Esteve Healthcare S.L. for total consideration of $244.5M including $34.5M contingent earnout. Resulted in pre-tax gain of $5.8M and prior goodwill impairment of $22.1M.
sustainability_report p.47
Annual Sustainability Report includes appendices informed by the Global Reporting Initiative (GRI), Sustainability Accounting Standards Board (SASB), and United Nations Sustainable Development Goals. Specific SDG numbers not enumerated in the 10-K excerpt.
sustainability_report p.14
Sold Hospital & Specialty Business to General Pharma BidCo Pty Ltd (Genesis Capital) for $13.3M.
sustainability_report p.47
Three-year global investment and efficiency program initiated Q1 2024, expected to deliver annualized pre-tax savings of $140M-$170M by end of 2026 with restructuring charges of $140M-$160M. Expected ~6% net reduction of total Perrigo roles.
sustainability_report p.40
The 10-K does not disclose a specific carbon removals strategy (no mention of DAC, BECCS, biochar, afforestation, or removal credit purchases). Net-zero plan is framed entirely around emissions reductions (production footprint, renewable energy, product/packaging redesign, EV fleet) rather than removals or offsetting. Detailed climate performance is referenced as being in the annual CDP disclosure and Sustainability Report which are not incorporated by reference.
sustainability_report p.14
Perrigo explicitly cites switching to electric vehicle fleets for its international business as part of its net-zero plan, targeting mobile combustion emissions in its CSCI operations.
sustainability_report p.14
Perrigo's stated goal is to reach net zero greenhouse gas emissions across its supply chain and operations by 2040. Plan involves reducing direct and indirect emissions by minimizing production footprint, buying renewable energy, redesigning products/packaging, and switching to electric vehicle fleets for international business.
sustainability_report p.14
As part of its net-zero-by-2040 ambition, Perrigo states its plan involves reducing direct and indirect emissions by minimizing its production footprint, buying renewable energy, redesigning products and packaging, and switching to electric vehicle fleets for its international business. No specific PPA volumes, RE100 status, or % renewable electricity figures are disclosed in the 10-K.
sustainability_report p.14
Perrigo intends to reduce direct emissions by minimizing its production footprint. The Supply Chain Reinvention Program (initiated 2022) is reducing portfolio complexity, optimizing manufacturing assets and distribution models, and diversifying sourcing — actions that overlap with operational decarbonisation through consolidation and efficiency.
sustainability_report p.14
Net-zero plan involves redesigning products and packaging. Separately, the firm states it is contributing to the circular economy by transitioning to reusable, recyclable, and compostable packaging where possible, with priorities including reducing packaging weight and innovating materials.
sustainability_report p.14
2022· 3 events
Completed acquisition of HRA Pharma for €1.8 billion (~$1.9B). Self-care company including Compeed, ellaOne, Mederma brands.
sustainability_report p.76
Purchased Nestlé's Gateway infant formula plant in Eau Claire, Wisconsin plus US/Canadian rights to GoodStart infant formula brand for $110.0M in cash.
sustainability_report p.78
Multi-year program initiated in 2022 to reduce structural costs, improve profitability, streamline global supply chain. Targets $200-300M annual run-rate savings by end of fiscal year 2028 with $300-350M in costs.
sustainability_report p.40